AB127. Unequal Access, unequal outcomes: disparities in availability and accessibility to self-injectable adrenaline for pediatric anaphylaxis in Asia-Pacific

Journal of Public Health and Emergency · 2026-07-01 · Registry study

Abstract

Background: Pediatric anaphylaxis is under-investigated in Asia-Pacific, with its management remains under-reported. This study aims to report and compare the management practice of pediatric anaphylaxis among Asia-Pacific localities.Methods: Data from the Asia-Pacific Research Network for Anaphylaxis, a prospective regional pediatric anaphylaxis registry with 16 participating centers from Hong Kong, Singapore, Thailand, and Qingdao, were analyzed. The management strategies across regions were compared. The outcomes of patients with and without self-injectable adrenaline before anaphylaxis were also contrasted.Results: A total of 721 anaphylaxis episodes in 689 patients, spanning from 2019 to 2022, were included. Overall, while adrenaline was administered in 434 (60.2%) episodes, only 64 (8.9%) were given pre-hospital adrenaline. Almost all patients in Thailand (95.8%, 113/118) and Singapore (93.3%, 237/254) received adrenaline, whose usage was significantly lower in Hong Kong (30.1%, 66/219) and Qingdao (13.8%, 18/130; P

Abstract © the authors or publisher, via OpenAlex. Reuse and removal

Tags

Adrenaline · Cardiovascular drugs · Children · Equity & disparities

Related articles